Depression and Alcohol Use May Contribute to Poor Treatment Adherence Differently in Men and Women - 10/19/07Most Patients on Lopinavir/Ritonavir-based HAART Achieve Complete Virologic Suppression with Adherence Rates Less Than 95% - 6/01/07Predictors of Antiretroviral Treatment Failure in an Urban HIV Clinic 1/19/07Alcohol Use as a Risk Factor for Poor Adherence and Treatment Failure 1/12/07Lower HAART Adherence Observed Prior to Viral Load "Blips" 9/29/06 The ´´95% Adherence Rule´´ May Not Apply to Lopinavir/Ritonavir (Kaletra)- based HAART Regimens - 8/25/06Do Once-Daily Regimens Improve Adherence to Antiretroviral Therapy? - 7/18/06 Boosted PIs Are More Forgiving of Non Adherence than Non-boosted PIs or NNRTI - 2/28/06 Differences in Treatment Compliance Between Lopinavir/ritonavir (LPV/r) Given Once (QD) Versus Twice (BID) Daily Do Not Affect Virologic or Immunologic Outcomes. R Rhode and others. - 12/18/05 Twenty-six Percent of HIV Positive Adults Receiving Health Care Report Discrimination by a Health Care Provider - 11/02/05 Gender Differences among HIV Patients on Methadone Maintenance and Enrolled in an Antiretroviral Adherence Trial - 10/12/05 Adherence to Antiretroviral Treatment in Prisons - 9/23/05 Self-reporting of Adherence Correlates with Pharmacy Records and Is Practical for Use in Routine Clinical Care - 9/23/05 Lipodystrophy-associated Symptoms and Medication Adherence in HIV/AIDS - 9/23/05 Efficacy and Safety of Once-daily Combination Therapy with Didanosine, Lamivudine and Nevirapine in Treatment-naive HIV Patients - 9/23/05 Drug Concentration Control Provides No Apparent Help in HIV Salvage Therapy - 6/08/05 TDF+3TC+d4T Is Significantly Better Tolerated Than ZDV+3TC or ZDV+3TC+NFV as Non-occupational HIV Post-exposure Prophylaxis and Results in Improved Adherence - 5/27/05 Relationship between Adherence and the Development of Resistance in Antiretroviral-Naive HIV Patients Receiving Lopinavir/Ritonavir or Nelfinavir - 5/27/05 Adherence Is Better after Switching from Twice-daily to Once-daily Therapy for HIV: Treatment Simplification Using Stavudine Prolonged-release Capsules - 5/25/05 Drug Resistance More Likely in NNRTI plus NRTI Regimens Compared with Ritonavir-boosted Protease Inhibitors - 4/25/05 Patients Want Treatment Information Sources That Address Their Individual Needs and Concerns - 4/25/05 Comparison of GI Tolerability and Patient Preference for Treatment with the 625 mg and 250 mg Nelfinavir Tablet Formulations - 4/22/05 Antidepressant Treatment Improves Adherence to Therapy Among Depressed HIV Patients - 4/13/05 Viral Rebound in Patients on First-line, PI-containing HAART Suggests a Lack of Adherence Rather Than the Selection of Resistant Variants - 4/04/05 Long-Term Neuropsychiatric Disorders among Patients Using Efavirenz-Based HAART: Quality of Life, Psychologic Issues and Adherence - 4/01/05 In Patients with AIDS and CMV Positive, Detection of CMV Viremia with Plasma CMV DNA PCR Is Predictive of Death - 4/01/05 Medicinal Marijuana Improves Adherence to HIV Therapy in Patients with Chronic Nausea - 2/14/05 Effectiveness of Generic Fixed-Dose Combinations of HAART in India - 2/07/05 Structured Treatment Interruptions: A Risky Business - 2/02/05 Comparison of Abacavir-based to Protease Inhibitor-based HAART Regimens: Patient Satisfaction and Adherence - 1/31/05 High Baseline Viral Loads and Substantial But Imperfect Levels of Adherence Are Major Predictors of Antiretroviral Resistance - 1/31/05 Alternation of Antiretroviral Drug Regimens for HIV Infection: Efficacy, Safety and Tolerability at Week 96 of the Swatch Study - 1/26/05 Intervention Helps Improve HIV Drug Adherence - 1/26/05 Among HIV Patients with Nausea, Medicinal Use of Marijuana May Aid Adherence to Antiretroviral Therapy - 1/21/05 Imperfect Adherence to HAART Fuels HIV Drug Resistance - 1/19/05 Similar Adherence Rates Favor Different Virologic Outcomes for Patients Treated with Non Nucleoside Analogues or Protease Inhibitors - 1/10/05
